AU Patent

AU2007225088B2 — Aminoquinolones as GSK-3 inhibitors

Assigned to Kyorin Pharmaceutical Co Ltd · Expires 2012-09-13 · 14y expired

What this patent protects

Provided herein are aminoquinolones and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating, preventing or ameliorating GSK-3 mediated diseases.

USPTO Abstract

Provided herein are aminoquinolones and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating, preventing or ameliorating GSK-3 mediated diseases.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007225088B2
Jurisdiction
AU
Classification
—
Expires
2012-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Kyorin Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.